SANDOZ GROUP AG by Sandoz Group AG (SDZXF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 2.30K

Day Range

- - -

52 Wk Range

55.50 - 94.55

Market Cap

P/E Ratio

60.72

Dividend Yield

1.15%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Sandoz Group AG News

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.

Vandana Singh

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

Multiple sclerosis patients report severe side effects, including relapses and mobility issues, after switching from Tysabri to Tyruko in an NHS cost-saving move. Regulators and experts are assessing the impact.

Vandana Singh

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

Coherus sells Udenyca franchise for up to $558.4 million, shifts focus to immuno-oncology R&D, and plans clinical trials in hepatocellular carcinoma and NSCLC.

Vandana Singh

UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.

Vandana Singh

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab

Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.94B

Investing Cash Flow (TTM)

-2.20B

Financing Cash Flow (TTM)

148.00M

Free Cash Flow (TTM)

954.00M

Capital Expenditure (TTM)

-988.00M

Net Change in Cash (TTM)

-110.00M

Valuation Metrics

Enterprise Value

$42.04B

PE Ratio (TTM)

60.72

PE Ratio (FWD)

19.34

PEG Ratio (TTM)

1.13

PS Ratio (TTM)

3.35

PB Ratio (TTM)

4.29

Earnings Yield % (TTM)

1.65%

Earnings Yield % (FWD)

5.17%

EV / EBITDA (TTM)

26.02

Price / EBITDA (TTM)

23.74

Price / Free Cash Flow (TTM)

40.99

Book Value / Share

$20.80

Company Debt

Total Debt

$5.85B

LT Debt

$4.47B

LT Debt Issuance (TTM)

$706.00M

LT Debt Repayment (TTM)

Total Cash

$1.25B

Debt to Equity

0.69

Issuance of Debt (TTM)

$706.00M

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 2.30K

Day Range

- - -

52 Wk Range

55.50 - 94.55

Market Cap

P/E Ratio

60.72

Dividend Yield

1.15%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Pharmaceuticals

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules an...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

SDZXF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

SDZXF

FAQ

How do I buy SANDOZ GROUP AG by Sandoz Group AG (SDZXF) stock?

You can purchase shares of SANDOZ GROUP AG by Sandoz Group AG (OTCQX:SDZXF) through any online brokerage.

View our list of the best stock brokerages

Who are SANDOZ GROUP AG by Sandoz Group AG (SDZXF) competitors?

There are no as such competitors for SANDOZ GROUP AG by Sandoz Group AG.

What is the forecast, or price target, for SANDOZ GROUP AG by Sandoz Group AG (SDZXF) stock?

There is no analysis for SANDOZ GROUP AG by Sandoz Group AG to provide a consensus price target.

What is the current price for SANDOZ GROUP AG by Sandoz Group AG (SDZXF)?

The stock price for SANDOZ GROUP AG by Sandoz Group AG (OTCQX: SDZXF) is $89.26 last updated August 25, 2026 at 2:21 PM EDT.

Does SANDOZ GROUP AG by Sandoz Group AG (SDZXF) pay a dividend?

There are no upcoming dividends for SANDOZ GROUP AG by Sandoz Group AG.

When is SANDOZ GROUP AG by Sandoz Group AG (OTCQX:SDZXF) reporting earnings?

SANDOZ GROUP AG by Sandoz Group AG does not have any upcoming earnings scheduled.

Is SANDOZ GROUP AG by Sandoz Group AG (SDZXF) going to split?

There is no upcoming split for SANDOZ GROUP AG by Sandoz Group AG.

What sector and industry does SANDOZ GROUP AG by Sandoz Group AG (SDZXF) operate in?

SANDOZ GROUP AG by Sandoz Group AG is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.